Šalis: Malta
kalba: anglų
Šaltinis: Malta Medicines Authority
DEXTROMETHORPHAN HYDROBROMIDE, DIPHENHYDRAMINE HYDROCHLORIDE
Thornton & Ross Limited Linthwaite Laboratories, Huddersfield, HD7 5QH, United Kingdom
R05DA
DEXTROMETHORPHAN HYDROBROMIDE 6.65 mg/5ml DIPHENHYDRAMINE HYDROCHLORIDE 10 mg/5ml
ORAL SOLUTION
DEXTROMETHORPHAN HYDROBROMIDE 6.65 mg/5ml DIPHENHYDRAMINE HYDROCHLORIDE 10 mg/5ml
OTC
COUGH AND COLD PREPARATIONS
Withdrawn
2006-11-01
PCP HEADER BOX APPROVED BY DATE OPERATOR ARTWORK NO CRN FIX REASON F SUF OR CHANGE ISSUED BY DATE MHRA/IMB SUBMISSION REQUIRED Yes A gill.kennedy 486062 11024 Addition of driving warnings at the request of the MHRA MHRA HEADER BOX PRODUCT TITLE C FONTS USED OLOURS USED COMPONENT PACK SIZE IG CODE DIMENSIONS PROOF NO. DATE Portrait single ply front label 150ml 22575207 90 x 50mm 2 21.05.2014 Process Black PANTONE 2685 C PANTONE 2725 C PANTONE 485 C PANTONE 7443 C Keyline (Does not print) Braille Covonia Night Time Formula Futura Helvetica 22575207 NEW ADVICE FOR DRIVERS - SEE REVERSE 22575207 Braille Reads c o v o n i a n i g h t t i m e f o r m u l a Braille Warning! Chesapeake cannot accept responsibility for any errors in this proof after approval by the customer. Whilst extreme care is taken in the setting of Braille, the customer must take the final responsibility for its accuracy. There is no single European Braille authority and there are many different Braille formats in existence, with country specific characters. This Braille is set to the Marburg Medium format unless you have requested otherwise. When you sign this proof you are signifying full approval of the Braille text and specification. Do not store above 25°C. Protect from light. MA HOLDER AND MANUFACTURER Thornton and Ross Ltd., Huddersfield, HD7 5QH, UK PL 00240/0042 92768591909 MA055/00503 COVONIA is a registered Trade Mark. P1 P2 92768591909 150ML 92768591909 P TURN OVER P3 COVONIA NIGHT TIME FORMULA is for night time relief of the symptoms of dry coughs and congestion from colds. SHAKE THE BOTTLE. Take the solution by mouth. ADULTS, THE ELDERLY AND CHILDREN OVER 12 YEARS: Take 3 x 5ml spoonfuls at bedtime. Repeat after 6 hours if required. DO NOT GIVE TO CHILDREN UNDER 12 YEARS OLD. DO NOT TAKE MORE MEDICINE THAN THE LABEL TELLS YOU TO. DO NOT TAKE WITH ANY OTHER COUGH AND COLD MEDICINE. AVOID ALCOHOLIC DRINK. THIS MEDICINE CAN LEAD TO DEPENDENCE. THEREFORE THE TREATMENT SHOULD BE OF SHORT DURATION. PEEL WHERE SHOWN FOR FURTHER PRECAUTIONS. Perskaitykite visą dokumentą
Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Covonia Night Time Formula 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Dextromethorphan Hydrobromide Ph.Eur. 6.65mg/5ml dose Diphenhydramine Hydrochloride Ph.Eur. 10.0mg/5ml dose Excipient(s) with known effect This medicine contains, per 15ml dose: 2.7g Maltitol, 3.675g Sorbitol, 869mg Ethanol, 18mg Sodium benzoate, 4.14mg Sodium. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral Solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the night time symptomatic relief of unproductive cough and congestive symptoms associated with colds. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Adults, the Elderly and Children over 12 years 3 x 5ml spoonfuls at bedtime. Repeat after 6 hours if required. CHILDREN UNDER 12 YEARS Do not give to children under 12 years old. Page 2 of 11 4.3 CONTRAINDICATIONS Contraindicated in known hypersensitivity to any of the ingredients. Contraindicated in persons under treatment with monoamine oxidase inhibitors or within 2 weeks of discontinuation of MAOI use. Contraindicated in persons under treatment with selective serotonin reuptake inhibitors (SSRIs) Dextromethorphan, in common with other centrally acting antitussive agents, should not be given to patients in, or at risk of developing, respiratory failure. Covonia Night Time Formula should not be used in liver dysfunction. It should not be administered to patients where cough is associated with asthma, or patients with productive cough. Diphenhydramine has been associated with acute attacks of porphyria and is considered unsafe in porphyric patients. Do not give to children under 12 years old. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Because of their antimuscarinic properties antihistamines should be used with care in conditions such as closed angle glaucoma, urinary retention, prostatic hyperplasia or pyeloduodenal obstruction. Caution should also be exercised in patients with epilepsy or severe cardiovascular disor Perskaitykite visą dokumentą